Culverwell Anthony Jamesinsider trades
In SEC Form 4 filings, Culverwell Anthony James is listed as Director of Quoin Pharmaceuticals, Ltd. (QNRX). In the last 90 days, Culverwell Anthony James bought $30K of Quoin Pharmaceuticals, Ltd. (QNRX) on the open market and sold none. The purchase was $30K of Quoin Pharmaceuticals, Ltd. (QNRX) on Aug 31. Took part in a cluster buy; the latest at Quoin Pharmaceuticals, Ltd. (QNRX), where 4 insiders bought within 1 day, ending Aug 31.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| QNRXQuoin Pharmaceuticals, Ltd. | Director | 3 | Sep 1 |
Cluster buys
- QNRX: 4 insiders bought $280K between Aug 31.
Form 4 historysince 2026-08-28
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| QNRXQuoin Pharmaceuticals, Ltd. | Aug 31 | Sep 1 | P | 6,146 | $4.88 | Purchase +$29,992 | 40,364 | No | Form 4 |
| QNRXQuoin Pharmaceuticals, Ltd. | Aug 31 | Sep 1 | P · derivative | 3,073 | $6.10 | Purchase +$18,745 | 3,073 | No | Form 4 |
| QNRXQuoin Pharmaceuticals, Ltd. | Aug 27 | Aug 28 | A | 31,352 | $5.15 | $161,463 | 34,218 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.